Liuwei Dihuang Lowers Body Weight and Improves Insulin and Leptin Sensitivity in Obese Rats

Table 3

Serum liver enzyme profile in obese rats in response to LWDH treatment^† (mean values with their standard errors, 𝑛=12).

	Control groups				LWDH-treated groups
	OR		OP		T1A		T1B		T1C
	Mean	SE	Mean	SE	Mean	SE	Mean	SE	Mean	SE
AST (U/L)	197.54	25.14	178.79	9.67	180.46	12.09	187.25	13.53	199.46	12.77
ALT (U/L)	38.00	1.83	46.04	1.95	44.88	1.51	41.88	1.16	44.45	2.06
ALP (U/L)	168.21	13.15	295.75	1.69	269.38	6.16	271.29	15.58	252.63*	11.68
GGT (U/L)	8.71	0.14	9.12	0.25	8.83	0.33	9.25	0.23	8.77	0.42

LWDH: Liuwei Dihuang; OR: obesity-resistant normal control group; OP: obesity-prone positive control group; T1A: 500 mg/kg/d LWDH group; T1B: 1500 mg/kg/d LWDH group; T1C: 3500 mg/kg/d LWDH group.
*Mean values within a row were significantly different from OP (pair-wise comparisons using the least squares means test; 𝑃<0.05).
^†The change in serum liver enzyme profiles in obese rats treated with total daily dosages of 500, 1500, or 3500 mg/kg BW LWDH is given.